Almost every phosphatidylserine RFQ contains the same four-line table: lead, arsenic, cadmium, mercury, with limits that look impressively strict. Almost no RFQ states the analytical method behind those limits, the sample preparation, or the reporting basis. The result is a specification that is simultaneously too strict for what the market rules require, too vague to be enforceable, and — when a brand's third-party screen later disagrees with the supplier's COA — impossible to resolve because the two numbers were never produced the same way.

Quality manager reviewing heavy metals specification tables with a supplier document pack on a laboratory desk

Heavy metals are not a reason to avoid phosphatidylserine — a well-run phospholipid process produces consistently clean material — but they are the single most common source of specification friction between PS buyers and suppliers. This article gives buyers the regulatory floor in the US and EU, the method questions that make results comparable, and a negotiation sequence that ends with a spec both sides can actually meet and defend. For the specification detail behind these documents, see our quality and R&D overview, including test methods and release criteria.

The Regulatory Floor: What US and EU Rules Actually Require

Start by separating what law requires from what caution suggests. In the US, dietary supplement manufacturers must establish specifications for contaminants under 21 CFR Part 111 and verify against them — but FDA does not publish numeric heavy metals limits for finished supplements. The de facto reference points are USP General Chapter <232> Elemental Impurities—Limits (with <233> procedures) and, more recently, the AHPA guidance levels for heavy metals in supplement ingredients. None of these binds your PS ingredient directly; your own spec does.

In the EU, Regulation (EU) 2023/915 on contaminants in food sets enforceable maximum levels for lead and cadmium in food supplements, and member state authorities enforce them against finished products. For a PS ingredient, the practical consequence is that your incoming spec must leave headroom below the finished-product limit once excipients and dosage are considered. Soymilk-derived phospholipids are not a high-risk matrix for metals compared with, say, botanicals from soil-exposed crops — which is precisely why an unreasonably strict PS spec costs you negotiating credibility with no safety gain.

Proposition 65 Changes the Math for US Brands

California's Proposition 65 is the real constraint for most US brands, because the safe harbor level for lead — 0.5 micrograms per day — is far below what general food law tolerates. The calculation is concentration times servings per day against the safe harbor, and it applies to exposure from the finished product, not the ingredient. A PS dose of 100–300 mg with lead at 0.1 ppm contributes 0.01–0.03 micrograms per day — comfortably inside the safe harbor. At 1.0 ppm lead it would not be.

This is why buyers should derive their lead limit from dose math, not from copying a neighboring line in someone else's template. If your highest-dose SKU is 300 mg/serving and you want a tenfold margin under the Prop 65 threshold, an ingredient limit around 0.15–0.2 ppm lead is defensible and achievable; specifying 0.02 ppm for a 300 mg dose is measurement theater — most labs cannot certify to it with statistical confidence on a routine basis, and you will spend the contract's life in retest disputes.

The Method Behind the Number: Why ICP-MS Details Matter

A heavy metals result is only as good as its preparation and method, and phospholipids are a demanding matrix — a fatty, waxy material that does not digest like an aqueous botanical extract. Your specification should state:

  • Technique: ICP-MS for low-level work (arsenic, cadmium, lead, mercury at sub-ppm), with ICP-OES acceptable only at looser limits.
  • Sample preparation: closed-vessel microwave digestion; dry-ashing or hot-plate digestion loses volatile analytes and produces low-bias arsenic and mercury results.
  • Mercury handling: cold-vapor or direct-mercury analysis where mercury limits are tight, because mercury adsorbs to digestion vessels.
  • Speciation awareness: total arsenic versus inorganic arsenic — total arsenic in a marine or phospholipid matrix can overstate risk; agree whether speciation testing is triggered and by what result.
  • Reporting basis and LOQ: results per kilogram of material as received, with the lab's limit of quantification stated on the COA — a "<0.02 ppm" result without an LOQ statement is unverifiable.

Require the supplier to name the testing lab, its accreditation (ISO/IEC 17025), and the method reference on every COA. Those three items do more for comparability than any change to the limits themselves.

Why COA Results and Third-Party Screens Disagree

When a brand's screen reports 0.09 ppm lead against a supplier COA of "<0.02," the explanation is usually one of five things: different digestion (extractable versus total), different technique with different sensitivity, a small and unrepresentative sample, sampling from a different layer of the drum (metals contamination often comes from the packaging environment, not the lipid), or genuine batch variation between production lots. Agree the dispute protocol in advance: retest the retained sample from the same lot at an agreed independent lab, with the retained sample's chain of custody defined, before the contract is signed. Negotiating this protocol after a failure is ten times harder.

Laboratory analyst preparing phospholipid samples for ICP-MS trace element analysis with closed-vessel digestion equipment

Negotiating the Specification: A Practical Sequence

Run the conversation in this order. First, fix your dose and market exposure math — Prop 65 for US SKUs, EU 2023/915 headroom for EU SKUs — and write the limit you can defend, not the limit that looks toughest. Second, ask the supplier for process data: their historical lot results for the last 12–24 months. A limit should sit above their process capability with margin, the same logic buyers apply to assay specs. If their lead results run consistently below 0.05 ppm, a 0.1 ppm limit gives both sides headroom; if they have occasional 0.08 ppm excursions, a 0.05 ppm limit manufactures nonconformances. Third, fix the method: ICP-MS, microwave digestion, stated LOQ, 17025-accredited lab. Fourth, define the failure protocol — retained sample, independent retest, and who pays if the retest confirms versus clears the original. Fifth, put sampling on a schedule: full heavy metals panel per production lot is the norm for a new supplier; periodic verification testing (every fifth or tenth lot, plus annual) is defensible once a track record exists and lowers cost for both sides.

Buyers who present this sequence get better specs and better prices; suppliers respect a limit they can see is derived from dose math and their own capability data, and they price risk accordingly. Buyers who present an arbitrary 0.02 ppm table get a COA written to pass, not to inform.

FAQ

Q: What heavy metals limits apply to phosphatidylserine in the US?

A: FDA sets no numeric heavy metals limits for supplement ingredients; your own specification under 21 CFR Part 111 is enforceable. USP <232> and AHPA guidance provide reference levels, and California Proposition 65 lead exposure (0.5 µg/day safe harbor) is usually the binding constraint — derive your lead limit from your highest dose per serving.

Q: What heavy metals limits apply to phosphatidylserine in the EU?

A: Regulation (EU) 2023/915 sets maximum levels for lead and cadmium relevant to food supplements, enforced against finished products. Your ingredient spec should sit below the finished-product limit with headroom for the dosage and excipients in your formula.

Q: Which analytical method should be specified for heavy metals in PS?

A: ICP-MS with closed-vessel microwave digestion, an ISO/IEC 17025-accredited laboratory, stated limits of quantification, and cold-vapor or direct mercury analysis where mercury limits are tight. Phospholipids need proper digestion — aqueous preparation methods produce low-biased results.

Q: Why do supplier COA results differ from my third-party test?

A: Typically differences in digestion method, technique sensitivity, sample representativeness or lot-to-lot variation. Define a dispute protocol in the quality agreement: retest the retained sample from the same lot at an agreed independent lab before escalation.

Q: How strict should my heavy metals spec be for a PS supplier?

A: Strict enough to keep finished products under regulatory and Proposition 65 exposure thresholds at your maximum dose, with margin — and no stricter. Ask for 12–24 months of the supplier's historical results and set the limit above their demonstrated process capability.

Conclusion

Heavy metals specifications for phosphatidylserine fail in two directions: too loose and they transfer risk to your brand; arbitrarily tight and they generate disputes, retests and supplier friction without adding safety. The fix is a derivation, not a template — regulatory floor for your markets, Proposition 65 dose math for the US, headroom for the EU, method details that make results comparable, and limits calibrated to the supplier's demonstrated process capability. Buyers who negotiate this way end up with specs that pass audits, hold up in disputes and cost less to administer. When you are ready to move from checklist to quotation, contact our team with the grade, source and document set described above.

Sources

  • U.S. Food and Drug Administration — 21 CFR Part 111, Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
  • California Office of Environmental Health Hazard Assessment — Proposition 65 Safe Harbor Levels: https://oehha.ca.gov/proposition-65/general-info/proposition-65-clearinghouse
  • European Commission — Regulation (EU) 2023/915 on maximum levels for certain contaminants in food: https://eur-lex.europa.eu/eli/reg/2023/915/oj
  • U.S. Pharmacopeia — General Chapter <232> Elemental Impurities—Limits (overview): https://www.usp.org/chemical-medicines/elemental-impurities

Buyer fit

Who this guide is for

This guide is written for the buyer profiles below. Open your profile for the matching grades, documents and next steps, or tell us your requirements directly.

Ask about this guide for your buyer profile

Recommended next steps

Contact sales for product documents

Share source preference, application, country, and annual quantity.

Contact Sales